Author:
Rabil Marie Jeanne,Tunc Sait,Bish Douglas R.,Bish Ebru K.
Abstract
AbstractAs new COVID-19 variants emerge, and disease and population characteristics change, screening strategies may also need to change. We develop a decision-making model that can assist a college to determine an optimal screening strategy based on their characteristics and resources, considering COVID-19 infections/hospitalizations/deaths; peak daily hospitalizations; and the tests required. We also use this tool to generate screening guidelines for the safe opening of college campuses. Our compartmental model simulates disease spread on a hypothetical college campus under co-circulating variants with different disease dynamics, considering: (i) the heterogeneity in disease transmission and outcomes for faculty/staff and students based on vaccination status and level of natural immunity; and (ii) variant- and dose-dependent vaccine efficacy. Using the Spring 2022 academic semester as a case study, we study routine screening strategies, and find that screening the faculty/staff less frequently than the students, and/or the boosted and vaccinated less frequently than the unvaccinated, may avert a higher number of infections per test, compared to universal screening of the entire population at a common frequency. We also discuss key policy issues, including the need to revisit the mitigation objective over time, effective strategies that are informed by booster coverage, and if and when screening alone can compensate for low booster coverage.
Publisher
Springer Science and Business Media LLC
Reference76 articles.
1. Nadworny, E. How Colleges are Dealing with High COVID Case Counts on Campus. https://www.npr.org/2022/01/23/1072730869/Omicron-college-campuses-covid-outbreaks. Accessed Jan 2022.
2. Johnson, A. G. COVID-19 incidence and death rates among unvaccinated and fully vaccinated adults with and without booster doses during periods of Delta and Omicron variant emergence-25 US jurisdictions, April 4–December 25, 2021. MMWR. Morb. Mortal. Wkly. Rep. 71, 1–10 (2022).
3. Iuliano, A. D. et al. Trends in disease severity and health care utilization during the early Omicron variant period compared with previous SARS-CoV-2 high transmission periods-United States, December 2020–January 2022. Morb. Mortal. Wkly. Rep. 71(4), 146–152 (2022).
4. Accorsi, E. K. et al. Association between 3 doses of mRNA COVID-19 vaccine and symptomatic infection caused by the SARS-CoV-2 Omicron and Delta variants. JAMA 327(7), 639–651 (2022).
5. CDC. Variant Proportions. https://covid.cdc.gov/covid-data-tracker/#variant-proportions. Accessed Feb 2022.
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献